Molecular origami: Protein engineering emerges to fight disease
(By Anna Vlasits for STAT) SEATTLE — Protein engineer Aaron Chevalier has a hunch that origami — on a smaller scale — could be
Read More
Part D/Prescription Drugs
Will Your Prescription Meds Be Covered Next Year? Better Check!
(By Alison Kodjak for NPR) The battle continues to rage between drug companies that are trying to make as much
Read MoreClinton and Trump are both wrong about Medicare’s ability to negotiate drug prices
(By Geoffrey F. Joyce and Neeraj Sood for STAT) Hillary Clinton and Donald Trump agree that Medicare bureaucrats should be
Read MoreDEA decision keeps major restrictions in place on marijuana research
(By Andrew Joseph for STAT) Federal drug enforcement authorities announced Thursday that they would continue defining marijuana as a drug
Read MoreNonprofit seeks to dispel ‘myths’ about how it assesses drug values
(By Ed Silverman for STAT) In the face of growing criticism over its efforts to place a value on new
Read MoreUS babies born addicted to opioids has tripled in 15 years, CDC says
(By Casey Ross for STAT) The number of babies being born in the United States addicted to opioids has tripled
Read MoreImprecise research threatens precision medicine
(By Spencer Phillips Hey and Aaron S. Kesselheim for STAT) The right treatment for the right patient at the right
Read MoreIRS is urged to investigate Gilead for ‘dodging’ US taxes
(By Ed Silverman for STAT) An advocacy group is urging the US Internal Revenue Service and the US Treasury Department
Read MoreInsurance Rules Can Hamper Recovery From Opioid Addiction
(By Jake Harper, Side Effects Public Media, for Kaiser Health News) Twice a day, Angela and Nate Turner of Greenwood,
Read MoreThe Future of Drug Pricing
Could global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of
Read More